What can we help you find?
A review of the dosing challenges and various dosage vials for emicizumab.
The panel provides an explanation on the appropriate dose calculation for factor VIII.
A review of the complications of self-administration and pain management.
Panelists review the dispensing process including storage requirements.
Experts review the procedures in an inpatient setting and discuss the patient education provided.
Panelists review the contraindication with emicizumab and aPCC.
The panel continues with a discussion of the treatment options and focuses on treatment with emicizumab.
With a review of the available treatment options, the panel moves into practice pearl #2, specifically factor VIII.
An introduction to practice pearl #1 with identifying severity of disease, and determining goals of therapy.
Experts identify patients considered for prophylaxis care and discuss determining individualized regimens.
Luigi Brunetti, PharmD, MPH, BCPS, BCGP, associate professor, Rutgers University Ernest Mario School of Pharmacy, and Robert Wood Johnson University Hospital, Somerset, New Jersey, moderates a discussion on best practices for hemophilia treatment. He is joined by Robert F Sidonio, Jr, MD, medical director of Hemophilia, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, and assistant professor of pediatrics,Emory University School of Medicine, Atlanta, Georgia; and Giles W. Slocum, Pharm.D., BCCCP, clinical pharmacy specialist, Emergency Medicine, Rush University Medical Center in Illinois.
Peter Salgo, MD will lead a panel of experts to identify the new, curative treatment options for hepatitis C, and restrictions to access.